URIC ACID (1,3-15N2)
- $490 - $1110
- Product name: URIC ACID (1,3-15N2)
- CAS: 62948-75-8
- MF: C5H4N4O3
- MW: 170.13
- EINECS:
- MDL Number:MFCD00145511
- Synonyms:URIC ACID (1,3-15N2);URIC ACID-1,3-15N2, 99 ATOM % 15N;URIC ACID-13-15N2 99%;15N Labeled uric acid;2,6,8-Trihydroxypurine-1,3-15N2;7,9-dihydro-3H-purine-2,6,8-trione;7,9-Dihydro-1H-purine-2,6,8(3H)-trione-1,3-15N2;Uric Acid-[15N2
4 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- Sigma-Aldrich
- TRC
Package
- 50mg
- 100mg
- 500mg
- ManufacturerMedical Isotopes, Inc.
- Product numberN1367
- Product descriptionUric acid-1,3-15N2
- Packaging50mg
- Price$490
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number490997
- Product descriptionUric acid-1,3-15N2 98 atom %
- Packaging500mg
- Price$1110
- Updated2024-03-01
- Buy
- ManufacturerTRC
- Product numberU829203
- Product descriptionUric acid-1,3-15N2
- Packaging50mg
- Price$535
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberU829203
- Product descriptionUric acid-1,3-15N2
- Packaging100mg
- Price$810
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | N1367 | Uric acid-1,3-15N2 | 50mg | $490 | 2021-12-16 | Buy |
Sigma-Aldrich | 490997 | Uric acid-1,3-15N2 98 atom % | 500mg | $1110 | 2024-03-01 | Buy |
TRC | U829203 | Uric acid-1,3-15N2 | 50mg | $535 | 2021-12-16 | Buy |
TRC | U829203 | Uric acid-1,3-15N2 | 100mg | $810 | 2021-12-16 | Buy |
Properties
Melting point :>300 °C (lit.)
storage temp. :Room Temperature
solubility :Aqueous Base (Slightly)
form :Solid
color :White to Off-White
storage temp. :Room Temperature
solubility :Aqueous Base (Slightly)
form :Solid
color :White to Off-White
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|